Stephens Inc Biolife Solutions Inc Transaction History

Stephens Inc

$7.43 Billion
Q3 2025

A detailed history of Stephens Inc transactions in Biolife Solutions Inc stock. As of the latest transaction made, Stephens Inc holds 15,953 shares of BLFS stock, worth $444,450. This represents 0.01% of its overall portfolio holdings.

Number of Shares

15,953

Holding current value

$444,450

% of portfolio

0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 27, 2025	BUY	$20.64 - $26.74 $329,269 - $426,583	15,953 New	15,953 $406,000
Q3 2024 Oct 28, 2024	SELL	$19.19 - $26.52 $363,899 - $502,898	-18,963 Reduced 33.98%	36,841 $922,000
Q2 2024 Aug 06, 2024	SELL	$15.14 - $22.99 $258,894 - $393,129	-17,100 Reduced 23.46%	55,804 $1.2 Million
Q1 2024 May 15, 2024	SELL	$15.35 - $18.82 $169,218 - $207,471	-11,024 Reduced 13.14%	72,904 $1.35 Million
Q4 2023 Feb 13, 2024	SELL	$8.99 - $16.86 $345,530 - $648,014	-38,435 Reduced 31.41%	83,928 $1.36 Million
Q3 2023 Nov 14, 2023	BUY	$10.81 - $22.96 $551 - $1,170	51 Added 0.04%	122,363 $1.69 Million
Q2 2023 Aug 14, 2023	BUY	$17.19 - $24.34 $317,946 - $450,192	18,496 Added 17.82%	122,312 $2.7 Million
Q1 2023 May 15, 2023	SELL	$17.67 - $26.07 $714,451 - $1.05 Million	-40,433 Reduced 28.03%	103,816 $2.26 Million
Q4 2022 Jan 25, 2023	BUY	$16.95 - $25.07 $98,259 - $145,330	5,797 Added 4.19%	144,249 $2.63 Million
Q3 2022 Nov 02, 2022	SELL	$14.64 - $26.7 $47,521 - $86,668	-3,246 Reduced 2.29%	138,452 $3.15 Million
Q2 2022 Aug 03, 2022	BUY	$10.54 - $24.2 $1.14 Million - $2.61 Million	107,800 Added 318.01%	141,698 $1.96 Million
Q1 2022 May 04, 2022	BUY	$20.81 - $37.29 $411,892 - $738,080	19,793 Added 140.33%	33,898 $771,000
Q4 2021 Mar 07, 2022	BUY	$32.99 - $58.55 $3,331 - $5,913	101 Added 0.72%	14,105 $526,000
Q3 2021 Oct 27, 2021	SELL	$42.03 - $60.5 $1,639 - $2,359	-39 Reduced 0.28%	14,004 $593,000
Q2 2021 Aug 12, 2021	BUY	$29.51 - $44.62 $22,781 - $34,446	772 Added 5.82%	14,043 $625,000
Q1 2021 May 14, 2021	SELL	$32.95 - $44.24 $76,971 - $103,344	-2,336 Reduced 14.97%	13,271 $478,000
Q4 2020 Feb 10, 2021	SELL	$27.5 - $45.75 $76,202 - $126,773	-2,771 Reduced 15.08%	15,607 $623,000
Q3 2020 Nov 13, 2020	BUY	$16.04 - $28.94 $32,593 - $58,806	2,032 Added 12.43%	18,378 $532,000
Q2 2020 Aug 24, 2020	BUY	$9.2 - $17.06 $3,192 - $5,919	347 Added 2.17%	16,346 $267,000
Q1 2020 May 14, 2020	BUY	$8.36 - $17.03 $133,751 - $272,462	15,999 New	15,999 $152,000

Others Institutions Holding BLFS

# of Institutions

208

Shares Held

50.5M

Call Options Held

Put Options Held

Casdin Capital, LLC New York, NY

7.71M
Shares

$215 Million
23.27% of portfolio
Black Rock Inc. New York, NY

5.49M
Shares

$153 Million
0.0% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

4.25M
Shares

$118 Million
0.06% of portfolio
Invesco Ltd. Atlanta, GA

3.58M
Shares

$99.8 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

2.9M
Shares

$80.7 Million
0.0% of portfolio

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.19B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account